Kendall Capital Management grew its position in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 29.9% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 7,799 shares of the specialty pharmaceutical company’s stock after buying an additional 1,795 shares during the quarter. Kendall Capital Management’s holdings in Jazz Pharmaceuticals were worth $959,000 […]